Drug Profile
Repinotan
Alternative Names: BAY 3702; BAY X 3702Latest Information Update: 24 Jan 2005
Price :
$50
*
At a glance
- Originator Bayer
- Developer Bayer; DevCo Pharmaceuticals
- Class Benzopyrans; Neuroprotectants; Small molecules; Thiazoles
- Mechanism of Action 5-HT1A serotonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Brain injuries; Stroke
Most Recent Events
- 23 Dec 2004 Discontinued - Phase-II for Stroke in Canada (IV)
- 23 Dec 2004 Discontinued - Phase-II for Stroke in Europe (IV)
- 23 Dec 2004 Discontinued - Phase-II for Stroke in Germany (IV)